UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences & biomedicine (101) 101
science & technology (101) 101
humans (92) 92
male (79) 79
female (77) 77
middle aged (71) 71
hematology (70) 70
adult (65) 65
aged (62) 62
oncology (48) 48
antineoplastic combined chemotherapy protocols - therapeutic use (44) 44
treatment outcome (40) 40
prognosis (34) 34
disease-free survival (32) 32
chemotherapy (29) 29
aged, 80 and over (26) 26
antineoplastic combined chemotherapy protocols - adverse effects (23) 23
neoplasm staging (23) 23
follow-up studies (21) 21
adolescent (20) 20
antineoplastic combined chemotherapy protocols - administration & dosage (20) 20
doxorubicin - administration & dosage (17) 17
cyclophosphamide - administration & dosage (16) 16
survival analysis (16) 16
hodgkin disease - drug therapy (15) 15
prospective studies (15) 15
vincristine - administration & dosage (15) 15
combined modality therapy (14) 14
prednisone - administration & dosage (14) 14
retrospective studies (14) 14
rituximab (14) 14
survival rate (14) 14
bleomycin - administration & dosage (13) 13
care and treatment (13) 13
kaplan-meier estimate (13) 13
hodgkin disease - pathology (12) 12
vidarabine - analogs & derivatives (12) 12
young adult (12) 12
lymphoma (11) 11
lymphomas (11) 11
multivariate analysis (11) 11
cancer (10) 10
drug administration schedule (10) 10
fludarabine (10) 10
remission induction (10) 10
toxicity (10) 10
abridged index medicus (9) 9
lymphoma, non-hodgkin - drug therapy (9) 9
survival (9) 9
vinblastine - administration & dosage (9) 9
cyclophosphamide - adverse effects (8) 8
dacarbazine - administration & dosage (8) 8
doxorubicin - adverse effects (8) 8
doxorubicin - therapeutic use (8) 8
etoposide - administration & dosage (8) 8
hodgkin disease - mortality (8) 8
italy (8) 8
methotrexate - administration & dosage (8) 8
predictive value of tests (8) 8
recurrence (8) 8
vidarabine - administration & dosage (8) 8
cyclophosphamide - therapeutic use (7) 7
disease progression (7) 7
dosage and administration (7) 7
hodgkin disease - diagnostic imaging (7) 7
leukemia, lymphocytic, chronic, b-cell - pathology (7) 7
lymphoma, follicular - drug therapy (7) 7
lymphoma, large b-cell, diffuse - drug therapy (7) 7
positron-emission tomography (7) 7
rituximab - administration & dosage (7) 7
stem cell transplantation (7) 7
stem cells (7) 7
transplantation, autologous (7) 7
vincristine - adverse effects (7) 7
analysis (6) 6
antibodies, monoclonal, murine-derived - administration & dosage (6) 6
bleomycin - adverse effects (6) 6
bleomycin - therapeutic use (6) 6
epirubicin - administration & dosage (6) 6
follicular lymphoma (6) 6
hodgkin disease - therapy (6) 6
hodgkin's disease (6) 6
incidence (6) 6
lymphoma, b-cell - drug therapy (6) 6
multiple myeloma (6) 6
prednisone - therapeutic use (6) 6
radiotherapy (6) 6
transplantation (6) 6
vincristine - therapeutic use (6) 6
antineoplastic agents - therapeutic use (5) 5
b-cll (5) 5
clinical trials (5) 5
cyclophosphamide (5) 5
cytarabine - administration & dosage (5) 5
dacarbazine - adverse effects (5) 5
fluorodeoxyglucose f18 (5) 5
hodgkin disease - radiotherapy (5) 5
hodgkin lymphoma (5) 5
immunophenotyping (5) 5
italy - epidemiology (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2009, Volume 374, Issue 9700, pp. 1512 - 1520
Summary Background Chemotherapy with high-dose methotrexate is the conventional approach to treat primary CNS lymphomas, but superiority of polychemotherapy... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Lymphoma, Non-Hodgkin - radiotherapy | Cranial Irradiation - methods | Central Nervous System Neoplasms - radiotherapy | Adult | Lymphoma, Non-Hodgkin - drug therapy | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Combined Modality Therapy | Remission Induction | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Cytarabine | Patient outcomes | Central nervous system diseases | Dosage and administration | Lymphomas | Drug therapy, Combination | Methotrexate | Drug therapy | Data analysis | Disease | Monoclonal antibodies | Data collection | Radiation therapy | Patients | Lymphoma | Tropical diseases | Index Medicus | Abridged Index Medicus
Journal Article
Supportive care in cancer, ISSN 1433-7339, 08/2010, Volume 19, Issue 10, pp. 1505 - 1510
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 04/2016, Volume 34, Issue 12, pp. 1376 - 1385
Journal Article
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 12/2005, Volume 23, Issue 36, pp. 9198 - 9207
Journal Article
The lancet oncology, ISSN 1470-2045, 03/2016, Volume 17, Issue 3, pp. 319 - 331
Journal Article
British journal of haematology, ISSN 0007-1048, 03/2016, Volume 172, Issue 6, pp. 879 - 888
Journal Article